Prae docs
Hari Baskar Balasubramanian B.Pharm, MSc
room: 2D257
tel: +43 1 4277 55305
e-mail: hari.baskar.balasubramanian@univie.ac.at
© OeAD/Klimpt
Hari Baskar Balasubramanian was awarded the ÖAW DOC Fellowship 2024 for his PhD project "Identification of the Metabolites Associated with a Dietary Intervention that Protect Against Hypertension-induced Cerebrovascular Injury"
© ÖAW/Natascha Unkart
© ÖAW/Natascha Unkart
Publications
Zeige Ergebnisse 1 - 10 von 10
Zille M, Balasubramanian HB, Ravi Kumar RK, Batzorig A, (ed.). Impact of null results in a PhD PhaNuSpo LifeSciences ScienceLife Podcast. 2025.
Tahir A, Balasubramanian HB, Kahr D, Haage F, Zille M. Aging of the blood-brain barrier: Metabolic signatures of mouse brain endothelial cell senescence. bioRxiv. 2025 Aug 18. doi: 10.1101/2025.08.14.670255
Balasubramanian HB, Biswas S, Talmon M, Patrucco F, Balbo PE, Fresu LG et al. Affinity of Nintedanib Towards New Candidate Target for Idiopathic Pulmonary Fibrosis. Borneo Journal of Pharmacy. 2024 Aug 30;7(3):264-277. doi: 10.33084/bjop.v7i3.7218
Lecchi G, Mocchetti C, Tunesi D, Berto A, Balasubramanian HB, Biswas S et al. Single-Nucleotide Polymorphisms of TAS2R46 Affect the Receptor Downstream Calcium Regulation in Histamine-Challenged Cells. Cells. 2024 Jul 16;13(14):1204. doi: 10.3390/cells13141204
Ben Nasr M, Usuelli V, Dellepiane S, Seelam AJ, Fiorentino TV, D'Addio F et al. Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule. Cell Metabolism. 2024 Jun 4;36(6):1302-1319.e12. doi: 10.1016/j.cmet.2024.05.001
Fotino C, Molano RD, Ben Nasr M, Umland O, Fraker CA, Ulissi U et al. Reversal of Experimental Autoimmune Diabetes With an sCD39/Anti-CD3 Treatment. Diabetes. 2023 Nov 1;72(11):1641-1651. doi: 10.2337/db23-0178
Jung S, Ben Nasr M, Bahmani B, Usuelli V, Zhao J, Sabiu G et al. Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes. Advanced Materials. 2023 Okt 5;35(40):2300812. doi: 10.1002/adma.202300812
Petrazzuolo A, Sabiu G, Assi E, Maestroni A, Pastore I, Lunati ME et al. Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease. Pharmacological Research. 2023 Apr;190:106710. doi: 10.1016/j.phrs.2023.106710
Loretelli C, Pastore I, Lunati ME, Abdelsalam A, Usuelli V, Assi E et al. eATP and autoimmune diabetes. Pharmacological Research. 2023 Apr;190:106709. doi: 10.1016/j.phrs.2023.106709
Aiyalu R, Lakshmanan K, Balasubramanian HB, Ramasamy A. Screening of iridoids and seco-iridoids in gentianaceae family against liver corrective targets using molecular docking studies. Research Journal of Pharmacy and Technology. 2019 Dez;12(12):5735-5738. doi: 10.5958/0974-360X.2019.00992.2
Zeige Ergebnisse 1 - 10 von 10